Published in Medical Letter on the CDC and FDA, May 20th, 2001
The clinical trial will take place at approximately 20 sites with an estimated 178 treated and control subjects.
Smaller than any other LVAD on the market, the MicroMed DeBakey VADR has been implanted in 85 patients to date. Measuring just 1" x 3" and weighing less than four ounces, the MicroMed DeBakey VAD is a miniaturized axial flow heart-assist pump one-tenth the size of currently...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.